EU approves German state aid for Sanofi Frankfurt insulin plant
SNY•The European Commission approved public support for Sanofi’s new Frankfurt insulin plant in September 2026, and construction began today; full insulin active ingredient production is planned for 2032, subject to licensing.
1. Plant construction begins
The European Commission approved German federal, Hesse and Frankfurt public support for Sanofi’s new Frankfurt insulin plant in September 2026. Construction began today, with full insulin active ingredient production planned for 2032, subject to licensing.
